يعرض 1 - 10 نتائج من 47 نتيجة بحث عن '"N.I. Weijl"', وقت الاستعلام: 1.50s تنقيح النتائج
  1. 1

    المساهمون: Pathology

    المصدر: The Oncologist
    Oncologist
    The Oncologist, 26(10), 854-864. WILEY
    oncologist, 26(10), 854-864. AlphaMed Press

    وصف الملف: application/pdf; Print-Electronic

  2. 2

    المساهمون: Internal medicine, CCA - Cancer biology and immunology, Urology, CCA - Cancer Treatment and quality of life, Health Technology Assessment (HTA)

    المصدر: Westgeest, H M, Kuppen, M C P, van den Eertwegh, F A J M, van Oort, I M, Coenen, J L L M, van Moorselaar, J R J A, Aben, K K H, Bergman, A M, Huinink, D T B, van den Bosch, J, Hendriks, M P, Lampe, M I, Lavalaye, J, Mehra, N, Smilde, T J, Somford, R D M, Tick, L, Weijl, N I, van de Wouw, Y A J, Gerritsen, W R & Groot, C A U 2021, ' High-Intensity Care in the End-of-Life Phase of Castration-Resistant Prostate Cancer Patients : Results from the Dutch CAPRI-Registry ', Journal of Palliative Medicine, vol. 24, no. 12, pp. 1789-1797 . https://doi.org/10.1089/jpm.2020.0800
    Journal of Palliative Medicine, 24(12), 1789-1797. Mary Ann Liebert Inc.
    Journal of Palliative Medicine, 24, 12, pp. 1789-1797
    Journal of Palliative Medicine, 24, 1789-1797

    وصف الملف: application/pdf

  3. 3

    المساهمون: Health Technology Assessment (HTA), Medical Oncology, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Medical oncology, CCA - Cancer Treatment and quality of life

    المصدر: Clinical Genitourinary Cancer, 17, 5, pp. e946-e956
    Clinical Genitourinary Cancer, 17(5), E946-E956. Elsevier
    Clinical genitourinary cancer, 17(5), E946-E956. CIG MEDIA GROUP, LP
    Westgeest, H M, Kuppen, M C P, van den Eertwegh, A J M, de Wit, R, Coenen, J L L M, van den Berg, H P, Mehra, N, van Oort, I M, Fossion, L M C L, Hendriks, M P, Bloemendal, H J, van de Luijtgaarden, A C M, ten Bokkel Huinink, D, van den Bergh, A C M, van den Bosch, J, Polee, M B, Weijl, N, Bergman, A M, Uyl-de Groot, C A & Gerritsen, W R 2019, ' Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands ', Clinical Genitourinary Cancer, vol. 17, no. 5, pp. e946-e956 . https://doi.org/10.1016/j.clgc.2019.05.018
    Clinical Genitourinary Cancer, 17(5), e946-e956. Elsevier
    Clinical Genitourinary Cancer, 17, e946-e956

    وصف الملف: application/pdf

  4. 4

    المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Health Technology Assessment (HTA), Medical oncology, Urology, CCA - Cancer Treatment and quality of life, Internal medicine

    المصدر: European urology oncology, 4(4), 618-627. De Tijdstroom/Elsevier
    European Urology Oncology, 4, 618-627
    European urology oncology, 4, 618-627. Elsevier
    Kuppen, M C P, Westgeest, H M, van den Eertwegh, A J M, van Moorselaar, R J A, van Oort, I M, Coenen, J L L M, van den Bergh, A C M F, Mehra, N, Somford, D M, Bergman, A M, Ten Bokkel Huinink, D, Fossion, L, Geenen, M M, Hendriks, M P, van de Luijtgaarden, A C M, Polee, M B, Weijl, N I, van de Wouw, A J, de Wit, R, Uyl-de Groot, C A & Gerritsen, W R 2021, ' Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer : Results from the Dutch Castration-resistant Prostate Cancer Registry ', European Urology Oncology, vol. 4, no. 4, pp. 618-627 . https://doi.org/10.1016/j.euo.2019.09.005
    European Urology Oncology, 4, 4, pp. 618-627
    European Urology Oncology, 4(4), 618-627. Elsevier BV

    وصف الملف: application/pdf

  5. 5
  6. 6
  7. 7
  8. 8
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  9. 9
  10. 10